Bodal Chemicals Limited announced its Q3FY26 financial results and strategic land sale approvals during a Board meeting held on February 14, 2026. The company reported mixed quarterly performance while demonstrating strong nine-month results and strategic asset monetization initiatives.

Financial Performance Overview

The company's consolidated financial results showed varying performance across different periods. For Q3FY26, total income reached Rs. 5,046.57 million compared to Rs. 4,453.67 million in Q3FY25, representing significant growth in revenue generation.

Standalone Results Performance

The standalone financial results demonstrated stronger profitability metrics. For Q3FY26, the company achieved standalone net profit of Rs. 19.81 million compared to Rs. 72.68 million in Q3FY25. However, nine-month standalone performance showed substantial improvement with net profit of Rs. 165.20 million versus Rs. 89.95 million in the corresponding previous period.

Strategic Land Sale Approvals

The Board approved two significant land disposal transactions as part of ongoing asset rationalization and monetization strategy:

These strategic disposals will enable buyers to establish units that consume the company's byproducts chlorine and hydrogen, facilitating uninterrupted production and supporting achievement of top-line and bottom-line targets. The land sales will be executed at prevailing market rates.

Asset Monetization Activities

During the nine months ended December 31, 2025, the company completed disposal of non-core assets including parts of Unit-II and Unit-III located in Vatva, G.I.D.C., Ahmedabad. These inoperative units generated profit on sale of Rs. 263.50 million, contributing significantly to other income.

Regulatory and Operational Updates

The company implemented new Labour Codes effective November 21, 2025, resulting in increased gratuity liability of Rs. 17.97 million due to revised wage definitions. The trading window for company securities will reopen from February 17, 2026, following the results announcement.

Bodal chemicals Limited has announced that its Board of Directors will convene on February 14, 2026, to review and approve the company's quarterly financial performance. The meeting represents a key milestone in the company's regular financial reporting cycle.

Board Meeting Details

The board meeting is scheduled to take place on Saturday, February 14, 2026, with flexibility for both physical and virtual attendance. The company has arranged for the meeting to be held at its corporate headquarters or through video conferencing facilities.

Agenda Items

The board meeting will focus on two primary agenda items:

• Consideration and approval of standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2025
• Any other business matters with the Chairman's permission

Trading Window Restrictions

In accordance with SEBI regulations, Bodal Chemicals Limited has implemented mandatory trading restrictions. The company has notified all concerned persons, employees, and insiders about the closure of the trading window for dealing in company securities.

Corporate Communication

The formal intimation was communicated to both major stock exchanges where the company's shares are listed. Company Secretary and Compliance Officer Ashutosh B. Bhatt signed the notification on February 5, 2026, ensuring compliance with regulatory requirements for timely disclosure of material information to stakeholders.